<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-NWQ7174H</identifier><date>2018</date><creator>Barbič, Matija</creator><creator>Bordi, Giulia</creator><creator>Cvjetičanin, Branko</creator><creator>Herzog, Maruša</creator><creator>Kobal, Borut</creator><creator>Meglič, Leon</creator><creator>Noventa, Marco</creator><creator>Saccardi, Carlo</creator><creator>Škof, Erik</creator><creator>Vitagliano, Amerigo</creator><relation>documents/doc/N/URN_NBN_SI_doc-NWQ7174H_001.pdf</relation><relation>documents/doc/N/URN_NBN_SI_doc-NWQ7174H_001.txt</relation><format format_type="issue">3</format><format format_type="volume">52</format><format format_type="type">article</format><format format_type="extent">str. 307-319, VI</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">3029371</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-NWQ7174H</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">epitelijski rak</subject><subject language_type_id="slv">intervalna citoredukcijska operacija</subject><subject language_type_id="slv">jajčniki</subject><subject language_type_id="slv">preživetje</subject><subject language_type_id="slv">primarna citoredukcijska operacija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">zdravljenje</subject><title>comparison of survivals</title><title>Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer</title></Record>